We have previously demonstrated that ovine articular chondrocytes synthesis
e and release insulin-like growth factor binding protein-5 (IGFBP-5) which
subsequently undergoes proteolysis in the tissue culture medium. The IGFBP-
5 proteolytic activity has now been characterised and its substrate specifi
city analysed using recombinant IGFBP-5 and purified chondrocyte-derived IG
FBPs. Iodinated human recombinant IGFBP-5 was incubated with chondrocyte cu
lture or conditioned medium in the presence or absence of various inhibitor
s. Serine protease inhibitors aprotinin and heparin effectively inhibited t
he breakdown of IGFBP-5. Furthermore, insulin-like growth factor-I (IGF-I)
but not its structural analogues with reduced affinity for IGFBP-5, was als
o able to partially protect IGFBP-5 from degradation indicating that the as
sociation of IGF with the binding protein was required for the inhibition o
f the proteolytic activity. The inflammatory cytokine interleukin-l did not
have any effect on IGFBP-5 proteolysis. The proteolytic activity appears t
o be IGFBP-5-specific since the incubation of chondrocyte-derived IGFBPs wi
th chondrocyte conditioned medium resulted in the loss of IGFBP-5 while the
levels of the other two IGFBPs (IGFBP-2 and a 24 kDa IGFBP) remained uncha
nged. In conclusion, we show that IGFBP-5 is specifically cleaved by a seri
ne protease released by primary cultures of ovine articular chondrocytes an
d also demonstrate the ability of IGF-I to inhibit the proteolytic activity
both in cell culture and in cell-free conditions. (C) 1998 Elsevier Scienc
e B.V. All rights reserved.